RAER Therapeutics
PrivateLast Round
Accelerator
Sep 26, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RAER Therapeutics is a biotechnology company that develops innovative therapies for rare genetic diseases using a rapid, cost-effective screening platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RAER Therapeutics Comparables
Compare RAER Therapeutics with similar companies based on industry and business-model similarity.
RAER Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 26, 2025 |
RAER Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| P4 Precision Medicine Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 26, 2025
Secured funding from P4 Precision Medicine Accelerator.
RAER Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RAER Therapeutics's valuation, stock price, and market status.
Is RAER Therapeutics a public or private company?
RAER Therapeutics is a private company.
What is the current stock price of RAER Therapeutics?
RAER Therapeutics is a private company with no public stock price. Caplight tracks RAER Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is RAER Therapeutics worth (valuation)?
Valuation information for RAER Therapeutics is not publicly available.
Can I buy RAER Therapeutics stock?
RAER Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RAER Therapeutics's last funding round?
RAER Therapeutics's most recent funding round was Accelerator on September 26, 2025.
Who are the main investors in RAER Therapeutics?
Key investors in RAER Therapeutics include P4 Precision Medicine Accelerator.
Will RAER Therapeutics IPO soon?
No public IPO plans have been announced for RAER Therapeutics.
How can I track RAER Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RAER Therapeutics's secondary market activity and sign up for updates.